The 22nd Edition of the European Meeting on HIV & Hepatitis will take place as a hybrid meeting on May 22-24 2024 in Barcelona, Spain

Barcelona, Spain – We can confirm that the 22nd Edition of the European Meeting on HIV & Hepatitis will take place as a hybrid meeting on May 22-24 2024 at Hotel Catalonia Barcelona Plaza in Barcelona, Spain.

Founded more than twenty years ago as the European HIV Resistance Workshop, theEuropean Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance has evolved to embrace all aspects of the clinical care of people living with HIV in Europe. This workshop places emphasis in particular on optimal treatment strategies, clinical virology, molecular epidemiology, and public health aspects of HIV, HBV, HCV, as well as emerging viruses throughout Europe.

In the last decade, the meeting has been able to capture leading clinicians and researchers from different regions of Europe. As such, this meeting is the only European platform where HIV-treating physicians and clinical virologists get together on an annual basis to present their latest research results and discuss their clinical implications in detail.

For further details about the congress, including registration, please click here.

 

Who Should Attend
Primary: Europe-based clinicians/physicians and researchers involved in the fields of HIV, HBV, and HCV.

Secondary: Laboratory managers, technicians, pharmacists, and pharmacologists.

– Residents, post-graduates, and PhD students

– Government agency personnel, NGO representatives, and health authority personnel

– Industry representatives

– Social workers, advocates, and community workers

– Other healthcare professionals involved in treating HIV and co-infected patients

 

Meeting Objectives
– Gather professionals in the fields of HIV and hepatitis clinical care and research in an interactive workshop setting;

– Provide a platform for presentation and discussion of the latest developments in the field of antiviral drug development;

– Map important current studies and results;

– Translate new data into treatment guidelines; and

– Educate clinicians on how to best implement current and new drugs in clinical practice.

Learning Objectives
After participating in this activity, participants will be able to:

– Summarize recent results (including clinical trial results) in drug development for HIV or Hepatitis.

– Apply the latest scientific results into daily clinical care to improve the quality of life of individuals living with HIV.

– Identify future challenges in the screening, monitoring and diagnosis of patients living with HIV or Hepatitis and develop new concepts for research and care strategies.

Meeting at a glance

When: May 22-24 2024

Venue: Hotel Catalonia Barcelona Plaza – Pl. d’Espanya, 8, Sants-Montjuïc Barcelona, Spain